https://www.selleckchem.com/pr....oducts/pkm2-inhibito
Intravenous corticosteroids are the mainstay of therapy for acute severe ulcerative colitis (ASUC), but 30%-40% of patients fail to respond. To investigate the effectiveness of exclusive enteral nutrition (EEN) as adjunctive therapy to intravenous corticosteroids in patients with ASUC. This was an open-label randomised controlled trial, in which patients who were admitted with ASUC between August 2018 and May 2020 were randomised 11 to EEN or standard of care (SOC). Patients on EEN received a semi-elemental formula fo
Like
Comment
Share
